Migraine: preventive treatment

被引:179
|
作者
Silberstein, SD
Goadsby, PJ
机构
[1] Thomas Jefferson Univ Hosp, Jefferson Headache Ctr, Philadelphia, PA 19107 USA
[2] UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, London WC1N 3BG, England
关键词
migraine; prevention; treatment; prophylaxis;
D O I
10.1046/j.1468-2982.2002.00386.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Migraine is a common episodic headache disorder. A comprehensive headache treatment plan includes acute attack treatment to relieve pain and impairment and long-term preventive therapy to reduce attack frequency, severity, and duration. Circumstances that might warrant preventive treatment include: (i) migraine that significantly interferes with the patient's daily routine despite acute treatment; (ii) failure, contraindication to, or troublesome side-effects from acute medications; (iii) overuse of acute medications; (iv) special circumstances, such as hemiplegic migraine; (v) very frequent headaches (more than two a week); or (vi) patient preference. Start the drug at a low dose. Give each treatment an adequate trial. Avoid interfering, overused, and contraindicated drugs. Re-evaluate therapy. Be sure that a woman of childbearing potential is aware of any potential risks. Involve patients in their care to maximize compliance. Consider co-morbidity. Choose a drug based on its proven efficacy, the patient's preferences and headache profile, the drug's side-effects, and the presence or absence of coexisting or co-morbid disease. Drugs that have documented high efficacy and mild to moderate adverse events (AEs) include beta-blockers, amitriptyline, and divalproex. Drugs that have lower documented efficacy and mild to moderate AEs include selective serotonin reuptake inhibitors (SSRIs), calcium channel antagonists, gabapentin, topiramate, riboflavin, and non-steroidal anti-inflammatory drugs.
引用
收藏
页码:491 / 512
页数:22
相关论文
共 50 条
  • [1] Preventive treatment of migraine
    Silberstein, Stephen D.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (08) : 410 - 415
  • [2] The preventive treatment of migraine
    Bigal, Marcelo E.
    Lipton, Richard B.
    [J]. NEUROLOGIST, 2006, 12 (04) : 204 - 213
  • [3] Preventive Treatment of Migraine
    Todd, Candice M.
    Sandoe, Claire H.
    Lay, Christine
    [J]. SEMINARS IN NEUROLOGY, 2022, 42 (04) : 503 - 511
  • [4] Preventive treatment of migraine
    Silberstein, SD
    Freitag, FG
    [J]. NEUROLOGY, 2003, 60 (07) : S38 - S44
  • [5] Preventive Migraine Treatment
    Silberstein, Stephen D.
    [J]. NEUROLOGIC CLINICS, 2009, 27 (02) : 429 - +
  • [6] Preventive Treatment of Migraine
    Shapiro, Robert E.
    [J]. HEADACHE, 2012, 52 : 65 - 69
  • [7] Memantine in the Preventive Treatment for Migraine and Refractory Migraine
    Krymchantowski, Abouch
    Jevoux, Carla
    [J]. HEADACHE, 2009, 49 (03): : 481 - 482
  • [8] Eptinezumab for the preventive treatment of migraine
    Villar-Martinez, Maria Dolores
    Moreno-Ajona, David
    Goadsby, Peter J.
    [J]. PAIN MANAGEMENT, 2021, 11 (02) : 113 - 122
  • [9] Atogepant for the Preventive Treatment of Migraine
    Ailani, Jessica
    Lipton, Richard B.
    Goadsby, Peter J.
    Guo, Hua
    Miceli, Rosa
    Severt, Lawrence
    Finnegan, Michelle
    Trugman, Joel M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08): : 695 - 706
  • [10] Preventive Treatment for Episodic Migraine
    Parikh, Simy K.
    Silberstein, Stephen D.
    [J]. NEUROLOGIC CLINICS, 2019, 37 (04) : 753 - +